Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

carvedilol phosphate

The phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and devoid of intrinsic… Expand
National Institutes of Health

Related topics

Related topics

20 relations
24 HR carvedilol phosphate 20 MG Extended Release Oral Capsule24 HR carvedilol phosphate 80 MG Extended Release Oral Capsule [Coreg]Adrenergic alpha-Antagonists [MoA]Angina Pectoris
Expand

Narrower (1)

Coreg

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial
Background Trastuzumab (TZB) is an established therapy for HER2‐positive breast cancer. The use of TZB is commonly associated… Expand
Is this relevant?
2014
2014
Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate
Abstract The objective of the study was to enhance the solubility of carvedilol phosphate and to formulate it into non… Expand
  • table I
  • table II
  • table III
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Adherence and dosing frequency of common medications for cardiovascular patients.
OBJECTIVES To compare adherence between once-daily (QD) and twice-daily (BID) dosing with chronic-use prescription medications… Expand
Is this relevant?
2012
2012
Quantifying the Structural Dynamics of Pharmaceuticals in the Glassy State.
Structural dynamics in the glassy state of two protic ionic liquids, carvedilol phosphate and procaine hydrochloride, were… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
In-vitro Release Study of Carvedilol Phosphate Matrix Tablets Prepared with Hydroxypropyl Methylcellulose
Purpose: To evaluate the effect of two molecular weight grades of hydroxypropyl methylcellulose on the release characteristics of… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • table 2
Is this relevant?
2012
2012
Formulation and Evaluation of Controlled Porosity Osmotic Drug Delivery System of Carvedilol Phosphate
Controlled porosity osmotic tablet of carvedilol phosphate prepared and evaluated in this study. Carvedilol phosphate is very low… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2011
2011
Formulation and characterization of an expandable, gastroretentive system of carvedilol phosphate by 32 factorial design.
UNLABELLED A 3(2) full factorial design was employed for the formulation and characterization of an expandable, gastroretentive… Expand
Is this relevant?
2011
2011
Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate.
OBJECTIVES Lipid nanoparticles as carrier for oral drug administration improve gastrointestinal solubility of poorly soluble… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH.
The effect of surfactants on the solubility of a new phosphate salt of carvedilol was investigated at different biorelevent pH to… Expand
  • figure 2
  • figure 3
  • figure 1
  • figure 4
  • figure 6
Is this relevant?
2009
2009
Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily…
BACKGROUND Suboptimal compliance in taking guideline-based pharmacotherapy in patients with chronic heart failure (HF… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE